JMI Syringes & Medical Devices Limited (DSE:JMISMDL)
119.10
-1.10 (-0.92%)
At close: Dec 4, 2025
DSE:JMISMDL Cash Flow Statement
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2016 |
| Net Income | 8.11 | 44.92 | 38.88 | -149.96 | 100.6 | 89.11 | Upgrade
|
| Depreciation & Amortization | 65.98 | 66.93 | 72.61 | 76.92 | 76.58 | 75.24 | Upgrade
|
| Other Amortization | 0.59 | 0.49 | - | - | - | - | Upgrade
|
| Other Operating Activities | 15.33 | 17.25 | 7.83 | 13.83 | 7.47 | 2.25 | Upgrade
|
| Change in Accounts Receivable | 17.5 | -63.23 | -106.42 | 24.47 | 75.33 | 193.44 | Upgrade
|
| Change in Inventory | -116.27 | 49.45 | 126.86 | -113.1 | -182.32 | -76.53 | Upgrade
|
| Change in Accounts Payable | 120.96 | 71.38 | 31.69 | -188.72 | 308.3 | -66.02 | Upgrade
|
| Change in Income Taxes | -96.52 | -91.32 | -89.79 | 205.99 | -163.03 | -105.56 | Upgrade
|
| Change in Other Net Operating Assets | -5.39 | 11.32 | 40.5 | 196.29 | -182.14 | 73.17 | Upgrade
|
| Operating Cash Flow | 10.3 | 107.19 | 122.16 | 65.72 | 40.78 | 185.1 | Upgrade
|
| Operating Cash Flow Growth | -91.22% | -12.26% | 85.87% | 61.15% | -77.97% | - | Upgrade
|
| Capital Expenditures | -9.65 | -7.98 | -12.7 | -44.44 | -97.86 | -60.3 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.01 | 1.15 | 1.97 | - | 0.05 | 0.53 | Upgrade
|
| Investing Cash Flow | -9.64 | -6.83 | -10.73 | -44.44 | -97.81 | -59.77 | Upgrade
|
| Short-Term Debt Issued | - | - | - | - | 160.08 | - | Upgrade
|
| Total Debt Issued | 14.77 | - | - | - | 160.08 | - | Upgrade
|
| Short-Term Debt Repaid | - | -21.72 | -80.33 | -82.02 | - | -76.8 | Upgrade
|
| Long-Term Debt Repaid | - | -0.8 | -2.01 | -0.84 | -5.37 | -4.86 | Upgrade
|
| Total Debt Repaid | 8.01 | -22.52 | -82.34 | -82.86 | -5.37 | -81.66 | Upgrade
|
| Net Debt Issued (Repaid) | 22.78 | -22.52 | -82.34 | -82.86 | 154.71 | -81.66 | Upgrade
|
| Common Dividends Paid | -30.65 | -30.03 | -29.73 | -0.24 | -68.76 | -65.65 | Upgrade
|
| Other Financing Activities | -7.09 | -8 | -7.9 | 21.8 | 17.02 | 39.22 | Upgrade
|
| Financing Cash Flow | -14.97 | -60.55 | -119.98 | -61.3 | 102.97 | -108.09 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | -0.08 | 0 | - | -0 | - | - | Upgrade
|
| Net Cash Flow | -14.39 | 39.8 | -8.55 | -40.01 | 45.94 | 17.24 | Upgrade
|
| Free Cash Flow | 0.65 | 99.2 | 109.46 | 21.29 | -57.08 | 124.8 | Upgrade
|
| Free Cash Flow Growth | -99.38% | -9.37% | 414.22% | - | - | - | Upgrade
|
| Free Cash Flow Margin | 0.04% | 5.27% | 6.10% | 1.21% | -2.34% | 6.26% | Upgrade
|
| Free Cash Flow Per Share | 0.02 | 3.30 | 3.64 | 0.71 | -1.90 | 4.15 | Upgrade
|
| Cash Interest Paid | 7.09 | 8 | 7.9 | 13.18 | 16.18 | 11.51 | Upgrade
|
| Cash Income Tax Paid | 96.52 | 91.32 | 89.79 | 110.27 | 163.03 | 105.56 | Upgrade
|
| Levered Free Cash Flow | 28.71 | 121.38 | 144.88 | 230.16 | -9.98 | 192.98 | Upgrade
|
| Unlevered Free Cash Flow | 28.86 | 121.65 | 146.46 | 238.24 | -1.74 | 199.96 | Upgrade
|
| Change in Working Capital | -79.72 | -22.4 | 2.84 | 124.93 | -143.86 | 18.5 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.